Difference plasma nitric oxide level between patients with heart failure NYHA II and NYHA IV

被引:0
|
作者
Pasah, R. R. [1 ]
机构
[1] Airlangga Univ, Dept Cardiol & Vasc Med, Surabaya, Indonesia
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:16 / 16
页数:1
相关论文
共 50 条
  • [1] Quality of life of hospitalized patients with heart failure, NYHA IV
    Kikira, A.
    Koutelekos, I.
    Parissopoulos, S.
    Tsami, A.
    Fouka, G.
    Polikandrioti, M.
    [J]. ARCHIVES OF HELLENIC MEDICINE, 2018, 35 (04): : 490 - 496
  • [2] Increased plasma level of apelin with NYHA grade II and III but not IV
    Ling Han
    Bingzhang Jie
    Jingguang Luo
    Liwei Chen
    Ye Jia
    Like Guo
    Yan Zhao
    Xin Chen
    Xiaogang Zhu
    Xu Teng
    Yongfen Qi
    [J]. Amino Acids, 2020, 52 : 823 - 829
  • [3] Increased plasma level of apelin with NYHA grade II and III but not IV
    Han, Ling
    Jie, Bingzhang
    Luo, Jingguang
    Chen, Liwei
    Jia, Ye
    Guo, Like
    Zhao, Yan
    Chen, Xin
    Zhu, Xiaogang
    Teng, Xu
    Qi, Yongfen
    [J]. AMINO ACIDS, 2020, 52 (05) : 823 - 829
  • [4] COST-EFFECTIVENESS ANALYSIS OF CARDIAC RESYNCHRONIZATION THERAPY IN PATIENTS WITH NYHA I AND NYHA II HEART FAILURE IN SPAIN
    Almenar, Luis
    Diaz, Beatriz
    Quesada, Aurelio
    Crespo, Carlos
    Marti, Belen
    Mealing, Stuart
    Linde, Cecilia
    Daubert, Claude
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2013, 29 (02) : 140 - 146
  • [5] Rationales and choices for the treatment of patients with NYHA class II heart failure
    Gilbert, Edward M.
    Xu, Weining David
    [J]. POSTGRADUATE MEDICINE, 2017, 129 (06) : 619 - 631
  • [6] Cardiac resynchronization therapy in NYHA class IV heart failure
    Khoo M.
    Kelly P.A.
    Lindenfeld J.A.
    [J]. Current Cardiology Reports, 2009, 11 (3) : 175 - 183
  • [7] Tolerability and efficacy of carvedilol in NYHA Class IV heart failure
    MacDonald, PS
    Keogh, AM
    Aboyoun, C
    Lund, M
    Amor, R
    [J]. CIRCULATION, 1997, 96 (08) : 3227 - 3227
  • [8] The benefits of daily hemofiltration in the management of anuria in patients with severe heart failure (NYHA IV)
    Iorio, L
    Simonelli, R
    Nacca, RG
    Saltarelli, G
    Violi, E
    [J]. INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1998, 21 (08): : 457 - 459
  • [9] Galectin-3 in a Sample of Hospitalized Class IV NYHA Heart Failure Patients
    Falcao, Luiz Filipe De Menezes
    De Boer, Rudolf A.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (18) : C109 - C109
  • [10] Acute therapy with Levosimendan (Simdax®) in decompensated heart failure NYHA IV
    Hardut, D.
    Eisenkoelbl, J.
    Elliott, P.
    Zweng, A.
    Weber, H.
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2006, 118 (17-18) : A41 - A42